413 related articles for article (PubMed ID: 32117800)
1. How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.
Klein C; Kahesa C; Mwaiselage J; West JT; Wood C; Angeletti PC
Front Cell Infect Microbiol; 2020; 10():23. PubMed ID: 32117800
[TBL] [Abstract][Full Text] [Related]
2. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa.
Ibrahim Khalil A; Mpunga T; Wei F; Baussano I; de Martel C; Bray F; Stelzle D; Dryden-Peterson S; Jaquet A; Horner MJ; Awolude OA; Trejo MJ; Mudini W; Soliman AS; Sengayi-Muchengeti M; Coghill AE; van Aardt MC; De Vuyst H; Hawes SE; Broutet N; Dalal S; Clifford GM
Int J Cancer; 2022 Mar; 150(5):761-772. PubMed ID: 34626498
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
5. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
Stewart TS; Moodley J; Walter FM
Cancer Epidemiol; 2018 Apr; 53():81-92. PubMed ID: 29414636
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review.
Okoye JO; Ofodile CA; Adeleke OK; Obioma O
Epidemiol Health; 2021; 43():e2021039. PubMed ID: 34044477
[TBL] [Abstract][Full Text] [Related]
7. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Weldegebreal F; Worku T
Cancer Control; 2019; 26(1):1073274819845872. PubMed ID: 31043067
[TBL] [Abstract][Full Text] [Related]
8. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
Farcasanu M; Kwon DS
Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis.
Olesen TB; Munk C; Christensen J; Andersen KK; Kjaer SK
Sex Transm Infect; 2014 Sep; 90(6):455-62. PubMed ID: 24812407
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
[TBL] [Abstract][Full Text] [Related]
13. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
Syst Rev; 2020 Apr; 9(1):88. PubMed ID: 32321580
[TBL] [Abstract][Full Text] [Related]
14. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
Bray F; Parkin DM;
Lancet Oncol; 2022 Jun; 23(6):719-728. PubMed ID: 35550275
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
Louie KS; de Sanjose S; Mayaud P
Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
[TBL] [Abstract][Full Text] [Related]
16. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
[TBL] [Abstract][Full Text] [Related]
17. Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership.
Godfrey C; Prainito A; Lapidos-Salaiz I; Barnhart M; Watts DH
Prev Med; 2021 Mar; 144():106295. PubMed ID: 33678226
[TBL] [Abstract][Full Text] [Related]
18. Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa.
Thomas JO
Semin Oncol; 2001 Apr; 28(2):198-206. PubMed ID: 11301383
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
Ba DM; Ssentongo P; Musa J; Agbese E; Diakite B; Traore CB; Wang S; Maiga M
Cancer Epidemiol; 2021 Jun; 72():101930. PubMed ID: 33756434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
